The structure of sandramycin, a novel antitumor antibiotic, was established by spectroscopic analysis and chiral chromatography of its acid hydrolysate.
(Received for publication July 10, 1992) The structure of sandramycin, a novel antitumor antibiotic, was established by spectroscopic analysis and chiral chromatography of its acid hydrolysate.
It was determined to be a cyclic decadepsipeptide with a two-fold axis of symmetry and 3-hydroxyquinaldic acid as an appended chromophore.
Sandramycin is a new antitumor antibiotic produced by a Nocardioides sp. (ATCC39419). Its production, isolation, characterization and biological properties were reported in a previous paper1}. The details of the structure determination and the assignment of chirality are described in this paper.
Results and Discussion
Because of the similarity in their antitumor activity, in their isolation pathway and in their chromatographic behavior, sandramycin was initially thought to be identical to luzopeptin A (formally called BBM-928)2~5). However, direct comparison of their UVand 1H NMRquickly dispelled this hypothesis. Their UVspectra were quite different and the XHNMRrevealed at least three differences between them. Proton coupling in the up field methyl signals of sandramycin suggested that the /Miydroxy-7V-methylvaline residue of luzopeptin A was missing and perhaps replaced by TV-methylvaline. A different chromophore was evident by the different UVspectra and by an additional aryl proton and missing aryl methoxy group in the *H NMRof sandramycin. Additional NMRresonances in the region of d 1.4 to 2.0 and the lack an acetyl group in sandramycin also suggested a difference at the tetrahydropyridazine residue of luzopeptin A. The identification and connection of the residues in sandramycin was accomplished by analysis of *H and 13C NMRdata and degradation studies.
Residue Identification
The XHand 13C NMRdata of sandramycin are shown in Tables 1 and 2 . From the^^H COSY and long-range 1H-1H COSYspectra6'7) the amino acids serine, glycine, sarcosine, 7V-methylvaline and pipecolic acid were readily identified by their respective spin systems as shown in Fig. 1 . Similarly, the aromatic chromophore, 3-hydroxyquinaldic acid, was identified from the 1H-1H COSYand 1H-13C heteronuclear multiple-bond correlation (HMBC)8)spectra of sandramycin with the couplings shown in Measured at 500 MHzwith a drop of DMSO-d6added for line sharpening. a Measured at 500MHzwith drop of DMSO-d6added for line sharpening. The molecular formula of sandramycin was established as C60H76O16N12as reported earlier1*. This JAN. 1993 Fie. 1. 1H-13C lone ranee couplines detected in the amino acids of sandramycin by HMBC. formula requires that the structure of sandramycin have twenty nine degrees of unsaturation. Fourteen of the twenty nine degrees were defined with the substructural elements identified and the partial sequence of the core. Since the molecular formula has twice the number of the carbon and proton atoms observed in the NMR spectra, sandramycin had to be a symmetrical dimer. The remaining degree of unsaturation could only be accounted for by a macrocyclic structure. The solid arrows indicate^-^C long range coupling.
The sites of dimerization and the attachment of the aromatic chromophore were revealed by 1H-13C HMBCand COLOC10)results as shown in Fig. 4 . The couplings to the carbonyl (C-l) at 3 169.3 from the serine /^-protons (19-H at 3 4.36 and 3 4.90) and the iV-methylvaline a-proton (2-H at 3 4.79), and an IR absorption band at 1748cm"1 showed that two core units were attached end to end through an ester bond at these residues. The site of attachment of the remaining 3-hydroxyquinaldic acid was assured by observing a^C-1!! long range coupling between the serine amide proton (25-H) at 3 9.50 and the quinoline carbon (C-2') at 3 134.4. From the data described above, the structure of sandramycin was determined to be as shown in Fig. 5 .
Chirality of Amino Acids A hydrolysate of sandramycin was examined by GCand HPLCto establish the configuration of the conditions. An HPLCchiral analysis was devised to separate iV-methyl-D,L-valine. It was determined that N-methyl-L-valine was present. All other compoundspresent separated from the peaks of interest.
Experimental
Spectroscopic Studies FAB-MS was measured on a Kratos MS-50spectrometer. IR spectra were recorded on a Beckmann IR4240 spectrophotometer. *H and 13C NMRspectra were recorded on a Bruker AM-500or a Bruker AM-300in CDC13with a drop of DMSO-d6(for line sharpening). Long range heteronuclear correlations were determined with HMBC and COLOCexperiments acquired at various mixing times (0.06~0.09 s) at 297K and 317K. Nuclear Overhauser effects were determined using the difference method at 297K.
Hydrolysis of Sandramycin A sealed tube containing 14.4mg of sandramycin in lml of 6n HC1 was heated to 110°C for 18 hours. After cooling, the reaction mixture was neutralized to pH 7 with Amberlite IRA-400 (OH) ion exchange resin, filtered and concentrated in vacuo to yield 13.4mg of hydrolysate. Chiral HPLCof Hydrolysate and Reference Amino Acids Hydrolysate and reference amino acids were assayed using the following HPLC method: Column-150 x4.6mm, 5^m, copper/L-proline column, prepared in-house, in situ11]; mobile phase 95% 1 mMcopper acetate (pH adjusted to 5 with dilute NaOH) -5% acetonitrile; flow rate 0.7ml/minute; detector 240 nm; diluent-MeOH to dissolve sample, then mobile phase. Approximate retention times: Af-Methyl-D-valine 1 1.5 minutes; iV-methyl-L-valine 1 6.6 minutes.
